VAT Trap Blog

Your statin reduces dangerous cholesterol particles brilliantly, but it cannot touch the metabolic engine room that created your heart disease. The insulin resistance, inflammation, and visceral fat driving your cardiovascular risk continue running unchecked unless you address them directly through targeted lifestyle interventions.

For fifty years, cardiology focused on cholesterol, blood pressure, and smoking. Yet patients with perfect numbers kept having heart attacks. The missing piece was visceral fat driving inflammation that standard risk models completely ignored.

Learn how to measure your waist correctly using anatomical landmarks to better assess visceral fat and cardiometabolic risk.

GLP-1 therapies reduce cardiovascular events, likely through visceral adipose tissue reduction, reframing cardiology treatment toward upstream metabolic disease targeting

Simple grip strength testing predicts heart disease better than blood pressure. Two three-minute muscle function tests reveal your metabolic resilience and can be tracked at home monthly. Strong muscles actively fight visceral fat accumulation across all cardiovascular risk factors.

Coronary calcium screening has evolved from expensive research tool to mainstream risk assessment, but fixation on Agatston scores obscures sophisticated plaque analysis. Zero calcium cannot exclude disease in younger patients, while elevated scores demand intensive prevention regardless of traditional risk calculations.